Notably, in the <28-week, 32–36-week, and 36–40-week groups, syncytin-1 mRNA copy number was significantly reduced in PE patients in cases of symptom-based suspicion of preeclampsia compared to no-PE women. This evidence concerns the gene ERVW-1 and preeclampsia.